Key result
Repeated levosimendan infusions undergo real-world evaluation for safety and efficacy in advanced heart failure outpatients.
Why the study?
Does repeated infusion of levosimendan improve efficacy and safety in outpatients with advanced heart failure?
Population
outpatients with advanced heart failure
Design
Cohort
Authors
Loading...
Real-world data support intermittent levosimendan consideration in advanced HF outpatients; leaves open efficacy confirmation by randomized trials.
Does repeated infusion of levosimendan improve efficacy and safety in outpatients with advanced heart failure?
Masarone et al. (2020) studied this question. Repeated infusion of levosimendan was evaluated for efficacy and safety in outpatients with advanced heart failure in a real-world setting.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: